Literature DB >> 1698512

Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia.

T Sakurada1, I Alufuzoff, B Winblad, A Nordberg.   

Abstract

Substance P-like immunoreactivity, choline acetyltransferase (ChAT) activity and muscarinic cholinergic receptors were measured in brains from 9 individuals with senile dementia of the Alzheimer type (AD), 4 individuals with multi-infarct dementia (MID), 6 individuals with mixed type of dementia (AD/MID) and 9 controls. The ChAT activity was markedly reduced (50-60%) in the hippocampus of all demented brains. The number of muscarinic cholinergic receptors was reduced only in the MID and AD/MID brains. No significant difference in substance P-like immunoreactivity was measured in 4 regions of AD brains in comparison to controls. In the combined MID plus AD/MID groups a significant reduction in substance P-like immunoreactivity (-35%) was measured in the hippocampus while no change was found in the frontal cortex, amygdala and caudate nucleus. The findings support the assumption of differences in selectivity of damage between AD and AD/MID, MID.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698512     DOI: 10.1016/0006-8993(90)91561-t

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

Review 1.  Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.

Authors:  A Leake; I N Ferrier
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

2.  Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type.

Authors:  R E Tato; A Frank; A Hernanz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

Review 3.  Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit.

Authors:  Paola Caruso; Riccardo Signori; Rita Moretti
Journal:  Vasc Health Risk Manag       Date:  2019-08-07

Review 4.  The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders.

Authors:  Michał Kosowski; Joanna Smolarczyk-Kosowska; Marcin Hachuła; Mateusz Maligłówka; Marcin Basiak; Grzegorz Machnik; Robert Pudlo; Bogusław Okopień
Journal:  Molecules       Date:  2021-05-11       Impact factor: 4.411

Review 5.  Risk factors for vascular dementia: hypotension as a key point.

Authors:  Rita Moretti; Paola Torre; Rodolfo M Antonello; Davide Manganaro; Cristina Vilotti; Gilberto Pizzolato
Journal:  Vasc Health Risk Manag       Date:  2008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.